461.93
Madrigal Pharmaceuticals Inc (MDGL) 最新ニュース
Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now - The Motley Fool
JPMorgan Chase & Co. Sells 8,030 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Aug Selloffs: How correlated is Madrigal Pharmaceuticals Inc to the S P5002026 Price Momentum & AI Powered Market Trend Analysis - baoquankhu1.vn
Madrigal outlines robust 2026 net sales growth and expanding pipeline amid 50% MASH market surge - MSN
Madrigal slides more than 5% as wider Q4 loss tempers strong sales growth - MSN
Madrigal Pharmaceuticals grants equity awards to 20 new employees - MSN
Madrigal inks licensing deal with China’s Suzhou Ribo for MASH drugs - MSN
Madrigal grants inducement awards to five employees - MSN
Madrigal Pharmaceuticals Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Avoiding Lag: Real-Time Signals in (MDGL) Movement - Stock Traders Daily
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Groupama Asset Managment Sells 13,447 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
MDGL Stock Price, Quote & Chart | MADRIGAL PHARMACEUTICALS INC (NASDAQ:MDGL) - ChartMill
2,600 Shares in Madrigal Pharmaceuticals, Inc. $MDGL Bought by Bamco Inc. NY - MarketBeat
Iron Triangle Partners LP Makes New Investment in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
First Light Asset Management LLC Takes Position in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals, Inc. $MDGL Stock Position Raised by Baker BROS. Advisors LP - MarketBeat
32,662 Shares in Madrigal Pharmaceuticals, Inc. $MDGL Bought by Ally Bridge Group NY LLC - MarketBeat
Madrigal Pharmaceuticals, Inc. $MDGL Shares Sold by ArrowMark Colorado Holdings LLC - MarketBeat
120,000 Shares in Madrigal Pharmaceuticals, Inc. $MDGL Purchased by Alkeon Capital Management LLC - MarketBeat
Madrigal Pharmaceuticals presence at Liver Connect Conference as attendance doubles - Traders Union
Avoro Capital Advisors LLC Cuts Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Is Rezdiffra’s Near‑US$1 Billion Debut Reshaping The Investment Case For Madrigal Pharmaceuticals (MDGL)? - simplywall.st
Connor Clark & Lunn Investment Management Ltd. Reduces Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
MDGL SEC FilingsMadrigal Pharmac 10-K, 10-Q, 8-K Forms - Stock Titan
Assessing Madrigal Pharmaceuticals (MDGL) Valuation After Recent Share Price Pullback - simplywall.st
Barclays PLC Cuts Stock Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals to Present Breakthrough Resmetirom Data at EASL Congress 2025 - MSN
Madrigal Pharmaceuticals Grants Equity Awards to 20 New Employees - MyChesCo
Is Madrigal Pharmaceuticals (MDGL) Pricing Look Interesting After Long Term Share Price Surge? - Yahoo Finance
2 Under-the-Radar Stocks to Buy and Hold - The Globe and Mail
What Makes Madrigal Pharma (MDGL) One of the Shorted Biotech Stocks to Buy - Finviz
Fieldview Capital Management LLC Invests $2.14 Million in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
10 Most Shorted Biotech Stocks to Buy According to Hedge Funds - Insider Monkey
Discipline and Rules-Based Execution in MDGL Response - Stock Traders Daily
Rhenman & Partners Asset Management AB Purchases Shares of 18,250 Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Madrigal Pharmaceuticals EVP Dier sells $854k in stock - Investing.com
Madrigal Pharmaceuticals EVP Dier sells $854k in stock By Investing.com - Investing.com South Africa
Pharma News: Why Madrigal Pharmaceuticals Inc. stock could be next big winnerTrade Volume Report & High Accuracy Swing Entry Alerts - Naître et grandir
Madrigal Pharmaceuticals (NASDAQ:MDGL) CFO Sells $853,984.34 in Stock - MarketBeat
Madrigal Pharmaceuticals (NASDAQ:MDGL) CEO Sells $718,316.22 in Stock - MarketBeat
Market Review: Why Madrigal Pharmaceuticals Inc. stock could be next big winnerPortfolio Update Summary & Stock Timing and Entry Methods - Naître et grandir
Madrigal Pharmaceuticals (NASDAQ:MDGL) General Counsel Sells $155,498.40 in Stock - MarketBeat
Insider Selling: Madrigal Pharmaceuticals (NASDAQ:MDGL) Director Sells 491 Shares of Stock - MarketBeat
大文字化:
|
ボリューム (24 時間):